Osanetant
id:
osanetant-175-12478137
title:
Osanetant
text:
Osanetant (developmental code name SR-142,801) is a neurokinin 3 receptor antagonist which was developed by Sanofi-Synthélabo and was being researched for the treatment of schizophrenia but was discontinued. It was the first non-peptide NK3 antagonist developed in the mid-1990s. Professor David J. Anderson, Director and Leadership Chair of the Tianqiao and Chrissy Chen Institute for Neuroscience at California Institute of Technology, has advocated that osanetant be explored as a treatment for pa
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Osanetant
date created:
2008-06-08T10:13:47Z
date modified:
2024-09-03T13:13:20Z
main entity:
{"identifier":"Q7105703","url":"https://www.wikidata.org/entity/Q7105703"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/3/39/Osanetant.png","width":1302,"height":1096}
fields total:
13
integrity:
16